Physician profile
Timothy Patrick Sullivan
NPI 1417944562
$1,000.25
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $233 · 2021: $318 · 2022: $156.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $310.05 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $255.49 | 2019-2021 | |
| Coopervision INC. | $91.94 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $58.44 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $54.87 | 2020-2022 | |
| Abbvie INC. | $47.90 | 2022 | |
| Alcon Vision LLC | $33.73 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $30.80 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $29.47 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $16.72 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.99 | 2022 | |
| Oyster Point Pharma, INC. | $14.77 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $14.55 | 2020 | |
| Ocular Therapeutix, INC. | $13.65 | 2020 | |
| Sun Pharmaceutical Industries INC. | $12.88 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.